Serum - Protection from birth onwards
MenFive® is indicated for active immunization of individuals aged 1-85 years against invasive meningococcal disease caused by Neisseria meningitidis groups A, C, Y, W, and X.
MenFive® is for intramuscular (IM) injection only, preferably in the deltoid muscle. In children below 5 years of age, anterolateral aspect of thigh may be used as alternate site if injection in deltoid muscle is not feasible.
MenFive® vaccination course consists of single dose of 0.5 ml.
Single-dose vaccine vial is reconstituted with 0.5 ml of provided diluent i.e. 0.9% sodium chloride.
5-dose vial: For the preparation of MenFive®, the 5-dose vaccine vial is reconstituted with 2.5 ml of provided diluent i.e. 0.9% sodium chloride.